viduals are screened with a self-rating measure, and those whose screen suggests a risk for PD can subsequently be interviewed by means of one of the recommended comprehensive instruments assessing PDs, for example the International Personality Disorder Examination (IPDE) [6] or the Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II) [15] . Hence, self-rating measures should detect, to the greatest degree possible, individuals with PD (high sensitivity; SENS), while also excluding those without PD (high specificity; SPEC). Although psychopharmacological and psychosocial interventions require and rely on the identification of the diagnoses, screening measures were not incorporated into current guidelines for treatment of PDs [e.g., [16] [17] [18] .
While self-rating inventories for screening PDs (e.g., the SCID Screen Questionnaire [19] , the Personality Diagnostic Questionnaire 4 + [20] , the Assessment of DSM-IV Personality Disorders Questionnaire [21] , and the Wisconsin Personality Disorder Inventory-IV [22] ) showed high SENS values, they have poor to moderate agreement with diagnoses, which was assessed by corresponding semi-structured interviews. Furthermore, those measures are lengthy (94-124 items) and, hence, time consuming for both patients and clinicians, which may limit their practical utility. To the best of our knowledge, there are 10 studies that examine short screening measures for PDs. These studies consist of 5 interviews [23] [24] [25] [26] [27] and 5 self-rating measures [12, [28] [29] [30] . As seen in table 1 , several methodical issues have to be considered in the course of evaluating the diagnostic efficiency of the available screening measures: (a) interviews might commonly be more time consuming than self-rating measures, with the exception of 2 self-rating measures with 44-47 items [12] ; (b) the results of 5 studies [12, [23] [24] [25] 30] were based on a small sample size (n = 52-90), although receiver operating characteristic (ROC) analysis, the most frequently applied method to examine diagnostic efficiency requires a sample size with at least 100 individuals [31] ; (c) some results were based on the same sample [12, 28, 29, 32] with high PD base rates (50-84%), whereas other results were based on mixed samples that were recruited in out-, day-, and inpatient units [23] [24] [25] , although the base rate and the levels of PD psychopathology might affect findings [33] ; (d) to assess axis I disorders, structured clinical interviews were not used at all, although those disorders might mask PD psychopathology; (e) the validity procedure was circular, using the original interview material as validity criteria [23, 26, 32] ; (f) important psychometric properties and specific characteristics (e.g., for internal consistency, discriminatory ability, and favored cutoff value) were not reported in each study [e.g., 23, 26 ] , and (g) the application in a twostage approach is in question due to low SPEC values (SPEC ^ 0.70); hence, after using the screening measure, in many cases a structured clinical interview has to be conducted to ensure that a PD is not present.
The Standardized Assessment of Personality -Abbreviated Scale Self-Rating Version (SAPAS-SR) [28] consists of 8 dichotomous items taken from the opening section of an informant-based interview assessing PDs in accordance with DSM-IV and ICD-10, the Standardized Assessment of Personality (SAP) [34] . Since the 8 items satisfactorily predicted the final SAP diagnosis of PD, the diagnostic efficiency of a self-rating version was examined in a small sample size (n = 60) providing preliminary evidence for the application in clinical practice [25] . Based on a large treatment-seeking outpatient sample (n = 195 [28] ), the self-rating version appeared to be efficient time wise as well as diagnostically (SENS = 0.83; SPEC = 0.80; overall corrected classification rate = 0.80). However, the prevalence rate of PDs was higher (50%) compared to the rate in a large, well-described outpatient sample (n = 859; 31%) [5] . Furthermore, the impact of axis I disorders on diagnostic efficiency could not be gauged, due to missing assessments. Hence, the present study examines the diagnostic efficiency of the German version of the SAPAS-SR in an outpatient sample, considering a lower base rate of PD as expected in outpatient samples and using stricter evaluation criteria.
Materials and Methods

Participants
Participants were 230 individuals (144 women, 86 men) consecutively admitted to the outpatient unit of the Technical University of Brunswick. All participants were white Europeans and participated on a voluntary basis. None of them received financial compensation. The local ethics committee approved the study. Every patient admitted to the outpatient unit between August 2009 and June 2010 granted their written, informed consent and took part in the assessment. Table 2 summarizes the socio-demographic characteristics of the participants. Sixty-six participants (28.7%) were diagnosed with at least one PD based on SCID-II experts' ratings (44 women, 22 men). A total of 164 participants (100 women, 64 men) without PD were included. No between-group differences were found regarding any sociodemographic data, with one exception: individuals with PD had used psychotherapy more often in the past. The prevalence rate was 1.33 8 0.69 PDs on average. From the total sample, 22% met the criteria for only 1 PD, 5% for 2 PDs, and 1% for 3 and 4 PDs, respectively. F igures are numbers and percentages in parentheses unless otherwise indicated. PD = Individuals with PD in accordance with the Structured Clinical Interview for DSM-IV Personality Disorders; without PD = participants with axis I disorders, but without PDs. F igures are numbers and percentages in parentheses. PD = Individuals with personality disorder in accordance with the Structured Clinical Interview for DSM-IV axis I disorders; without PD = participants with axis I disorders, but without PDs.
specific PDs in accordance with DSM-IV. Avoidant and borderline PDs were most prevalent in that sample, with rates of 20 and 7%, respectively. Table 4 summarizes the co-occurring axis I disorders in accordance with DSM-IV. The majority of participants met the criteria of any affective disorder (71.7%) and anxiety disorder (37.7%) . No between-group differences were found in the number of co-occurring axis I syndromes. The prevalence rate was 1.5 8 0.70 axis I disorders on average. No between-group differences were found in the total number of axis I disorders [t (227, n = 230) = 0.535, p = 0.593].
Measures
Standardized Assessment of Personality -Abbreviated Scale Self-Rating Version . In accordance with the guidelines for translation of foreign-language measures [35] , a German bilingual colleague translated the German version of the SAPAS-SR from the English version in 2008; it was then re-translated by a bilingual colleague, who was also a clinical psychologist. Small divergences were discussed and then resolved with the senior author. The 8 dichotomous items of the SAPAS-SR showed a low index for internal consistency in the previous study (Cronbach's ␣ = 0.45) [28] . These authors suggest that patients who receive a total score of 4 or higher on the SAPAS-SR should be further evaluated for PD.
Symptom Checklist-90-Revised . To obtain information on the severity of psychopathology, the Global Severity Index (GSI) of the German version of the Symptom Checklist-90-Revised (SCL-90-R) [36] was used. The GSI has been shown to have good internal consistency (Cronbach's ␣ = 0.97) in a German sample treated with psychotherapy. In the present study, internal consistency was the same, with Cronbach's ␣ = 0.97. [38] . Both interviews were used for classification of axis I disorders and PDs (on axis II). Three female licensed clinical psychologists had been trained in the administration and scoring of these instruments by one of the authors (C.K.), who is a licensed trainer for the SCID. They met once a week and discussed the ratings of diagnoses. The interrater reliability coefficient was median = 1 (0.77 ^ ^ 1).
Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) [37] and Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II)
Complexity Index . After assessing co-occurring mental disorders and diseases, pharmacological care, self-harming and suicidal behavior, and specific characteristics of interpersonal behavior during the assessment, interviewers were requested to recommend different interventions. In addition, they were asked to rate the expected complexity for treatment planning on a 5-point scale, ranging from 1 (very low) to 5 (very high).
Procedure
After a telephone inquiry that described the study, all participants were mailed a questionnaire for collecting sociodemographic data, along with the self-rating measures. Participants were asked to bring the completed materials to the appointment on the day when the interviews were conducted. A bachelor's level research assistant checked the self-rating measures for missing data and asked patients to complete data when necessary. Due to this procedure, the interviewers were blind to the results of the self-rating measures. Subsequently, participants were interviewed for axis I disorders and PDs. After analyzing the data, each participant was given written feedback and a recommendation for treatment.
Data Analyses
Internal consistency of the SAPAS-SR is reported as Cronbach's ␣ coefficient. In accordance with Waller [39] , the values of Cronbach's ␣ were corrected due to the probable bias in commingled samples. As indices of convergent validity, Spearman's rank correlation coefficients were calculated between the sum score of the SAPAS-SR and the SCID-II number of fulfilled criteria. Mean differences were tested by t and 2 statistics, depending on which scales of measurement were provided.
In the context of signal detection theory [40] , ROC analysis provides an approved method to evaluate the ability of biomarkers or other measures to distinguish individuals with diseases or disorders from those without. The area under the ROC curve (AUC) is an indicator for the diagnostic accuracy of the measure, which can range from 0.50 (random performance) to 1.0 (perfect performance). According to Swets [41] , values of 0.50 ! AUC ^ 0.70 indicate a low, 0.70 ! AUC ^ 0.90 a moderate, and 0.90 ! AUC ^ 1.0 a high discriminatory ability for the measure. To estimate the accuracy of different cutoff points, SENS, SPEC, positive predictive value (PPV), negative predictive value (NPV), and the overall correct classification rate (OCC) were calculated. Index J [42] was computed as the sum of percentages of correctly identified cases and non-cases minus 1 (J = SENS + SPEC -1) ranging from 0 to 1. For a screening measure, a J 1 0.50 was recommended. The maximal J indicates the optimal cutoff point obtained when the values of SENS and SPEC are maximized. However, in the face of the individual burden and several costs when an individual with PD is not identified, SENS might be weighted higher than SPEC. Due to the impact of the symptom spectrum on the ROCs [31] , the prevalence rate of PD in the total sample should be about 30%, and the distribution of PDs should be similar to that reported in the study by Zimmerman et al. [5] . The data was analyzed using SPSS 16.0 for Windows.
Results
Reliability and Validity Indices
Internal consistency value was small, with Cronbach's ␣ = 0.39, and moderate, with Cronbach's ␣ = 0.64, when corrected for commingled samples. As shown in table 5 , Spearman's rank correlation coefficients between the sum score of the SAPAS-SR and the ratings of each SCID's PD module were highly significant (p ! 0.001), ranging from = 0.21 to 0.48, with ratings for the schizoid PD module ( = 0.25, p ! 0.05) and the histrionic PD module as exceptions (the latter was not significant). Both PDs were less prevalent in that sample, and for both, variance was small.
As expected, individuals with PD showed higher scores on the general symptom strain (GSI) than individuals without PD [1. 
Diagnostic Efficiency
The AUC obtained for the SAPAS-SR was 0.67 (95% CI 0.59 ! AUC ! 0.74), indicating that the scale performed significantly better than chance (p ! 0.001). According to Zweig and Campbell [43] , this means that a randomly selected individual with PD is 67% more likely to have a higher score than a randomly chosen participant without PD.
In table 6 , cutoff points and operating characteristics are presented. Using the cutoff point of 4 for the SAPAS-SR, which is in accordance with the maximal J, 80% of individuals with PD (SENS) and 46% of individuals without PD were correctly identified (SPEC). The likelihood that individuals classified as PD did in fact fulfill the criteria was 37% (PPV), whereas the likelihood that individuals classified as non-PD did not meet the criteria for this disorder was 84% (NPV). The OCC was 55%. Using a cutoff point with a higher SENS value, hardly anybody without PD was correctly classified.
Using the cutoff point of 4, 10 out of 13 participants with PD diagnosed by the SAPAS-SR as non-PD met the criteria of a PD in the anxious cluster (8 individuals with avoidant and 2 with obsessive-compulsive PD); 3 were classified as PD in the dramatic cluster (borderline, narcissistic, and antisocial PD) in accordance with the SCID-II.
Discussion
This study examined the diagnostic efficiency of the SAPAS-SR in a German outpatient sample. The discriminatory ability was low (AUC ^ 0.70), according to Swets [41] . In addition, the J index did not reach the recommended amount for a screening measure (J 1 0.50) [42] . The favored cutoff point was identical to that in the study by Germans et al. [28] . Based on a similar PD prevalence rate of 28%, Walters et al. [27] estimated values for the informant ratings of the SAPAS with NPV = 0.87 and PPV = 0.37, respectively. In the present study, NPV and PPV turned out to be almost identical for the selfrating version. Compared to the study by Germans et al. [28] , the internal consistency value was higher in the present study, when corrected for commingled samples. Convergent validity was supported by small, but highly significant correlation coefficients, considering the different data sources (i.e., patient's self-rating and expert's interview) and the dichotomous response format of measures.
Using the SAPAS-SR in a two-stage approach, 53 individuals with PD might be less intensely examined by the SCID-II. This would save about 27 h of the expert's time, when 1/2 h per interview was postulated. Since the SPEC value was low (SPEC ^ 0.70) in the present study, 90 individuals without PD would be assessed by the SCID-II to ensure that no PD was present. The SPEC value might be affected by similar individual responses on specific items (e.g., to be a worrier, to depend on others), although those individuals showed mainly co-occurring anxiety and affective disorders. In addition, 10 individuals who met the criteria of a PD in the anxious cluster were not identified by the SAPAS-SR. We assume that high sensitivity to rejection and fear of disapproval during the admission procedure may lead to non-valid responses, contributing to the lowered SENS value. A further 3 unidentified individuals met criteria of PDs in the dramatic cluster, which is characterized by dissimulation, deception, and low self-reflection. For those PDs, informant-based ratings of the SAPAS might result in a better SENS value [24] . However, our findings should be regarded with caution, as the prevalence rates for narcissistic and antisocial PD were low in the present study (0.4% for each, based on 1 individual only) compared to a large, well-described outpatient sample (2.9 and 3.6%, respectively [5] ).
In sum, self-rating measures are prone to underdiagnose some PDs due to cognitive and interpersonal patterns of these disorders. Since some of those PDs, in particular borderline and obsessive-compulsive PD, were associated with high economic burden [11] and the false-positive rate for participants without PD was high, using the SAPAS-SR in a two-stage screening approach might result in only moderate cost efficiency.
Several limitations have to be taken into consideration. First, we were not able to use the Longitudinal Expert All Data Standard [44] . Our criterion for the presence or absence of PD was the SCID-II; hence, results were limited by the SENS of this interview. Second, PDs of the dramatic cluster and their symptom spectrum were not prevalent in the present sample as reported in the study of Zimmermann et al. [5] . This might contribute to a lowered SENS value, assuming that PDs of the dramatic cluster could be well identified. Some evidence comes from findings in a similar outpatient sample, where a self-rated screening measure for borderline PD showed high diagnostic efficiency (SENS = 0.91; SPEC = 0.80) [45] . Third, generalization of our findings was limited to outpatients, considering that different base rates of PD and symptom spectrum, as expected in an inpatient setting, primary care, or the general population, have an impact on the ROCs of screening measures. Although it is well known that PDs co-occur with substance use disorders [46] , individuals with both PD and substance use disorders were nearly absent in the present sample due to the specialization of the outpatient unit, which is recognized for the treatment of anxiety and affective disorders. Fourth, ROC analysis requires a classification into two subsamples (i.e., with and without PD), which seemed to be inappropriate when a dimensional assessment of personality is favored [e.g., 47 ]. Although a more detailed description based on the personality models might be clinically useful, clinicians and researchers must decide, on an empirical base, how much time and effort should be invested in additional assessments.
The treatment of outpatients is a major application setting in which screening measures will be used. Hence, one of the strengths of the present study is that a treatment-seeking outpatient sample was used, featuring a PD prevalence rate similar to that seen in clinically representative outpatient samples [5] . Another methodological strength of the study was the stricter evaluation criteria, showing that caution is advised on the usage of SAPAS-SR, in particular due to the low discriminatory ability and the SENS value. In addition, findings of the present study validate the cutoff point of 4 on the SA-PAS-SR.
Future research should use a large, well-described inpatient sample at admission, whose PD base rate and level of psychopathology is expected to be higher than that of an outpatient sample. Furthermore, the impact of gender or ethnicity on diagnostic efficiency remains unknown until further investigations are conducted. At the moment, the work group of DSM-V proposes a re-conceptualization of PDs. Hence, we propose that the diagnostic efficiency of the SAPAS-SR should be examined in two steps using, first, the level of personality functioning indicating whether a PD is present at all, and second, the PD types (antisocial/psychopathic, avoidant, borderline, narcissistic, obsessive-compulsive, and schizotypal) indicating specific personality traits.
